The Burden of Diabetes in a Developing Country


Introduction: People with diabetes often develop diverse microvascular, macrovascular, and neuropathic complications. Diabetes named high disease because of its high prevalence, high incidence, chronicity and high costs. Accurate projections of diabetes burden are essential for health planning so the aim of this study was to calculate the burden of diabetes in Razavikhorasan population, in Iran. Methodology: We used Disability Adjusted Life Years (DALYs) index using computer model (DisMod) for assessment of burden of diabetes and complications in Razavikhorasan province in Iran in year 2010-2011. Results: Burden of diabetes in Razavikhorasan population was 64,733 DALY in year 2010-2011. The total Years Life Lost (YLL) from diabetes mellitus was 62,883 (34,216 in men and 28,667 in women) due to premature death and the total Years Life Disability (YLD) was 1850. Conclusion: Diabetes mellitus and lesser forms of glucose intolerance can now be found in almost every population and epidemiological evidences suggest that, without effective prevention and control programs, diabetes will continue to increase and therefore advances in all levels of prevention may help reduce the number of people with diabetes.

Share and Cite:

Khajedaluee, M. , Dadgarmoghaddam, M. , Saeedi, R. , Izadi-Mood, Z. and Abrishami, M. (2014) The Burden of Diabetes in a Developing Country. Open Journal of Preventive Medicine, 4, 175-181. doi: 10.4236/ojpm.2014.44023.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Hazlett, B.E. (2000) Historical Perspective: The Discovery of Insulin. In: Davidson, J.K., Ed., Clinical Diabetes Mellitus: A Problem-Oriented Approach, Thieme, New York, 3-11.
[2] American Diabetes Association (2008) Standards of Medical Care in Diabete. Diabetes Care, 31, S12-S54.
[3] World Health Organization (1994) Prevention of Diabetes Mellitus. Technical Report Series No. 844. World Health Organization, Geneva.
[4] (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20, 1183-1197.
[5] Alberti, K.G. and Zimmet, P.Z. (1998) Definition, Diagnosis and Classification of Diabetesmellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of a WHO Consultation. Diabetic Medicine, 15, 539-553.<539::AID-DIA668>3.0.CO;2-S
[6] American Diabetes Association (2010) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 33, S62-S69.
[7] Wallace, R. (2008) Public Health & Preventive Medicine.15 Edition, McGrawHill, USA, 10.
[8] Engelgau, M.M., Geiss, L.S., Saaddine, J.B., Boyle, J.P., Benjamin, J.M., Gregg, E.W., Tierney, E.F., Rios-Burrows, N., Mokdad, A.H., Ford, E.S., Imperatore, G. and Narayan, K.M.V. (2004) The Evolving Diabetes Burden in the United States. Annals of Internal Medicine, 140, 945-950.
[9] Zimmet, P.Z., Alberti, K.G. and Shaw, J.E. (2001) Global and Societal Implications of the Diabetes Epidemic. Nature, 414, 782-787.
[10] King, H. and Rewers, M. (1993) WHO Ad Hoc Diabetes Reporting Group: Global estimates for Prevalence of Diabetes and Impaired Glucose Tolerance in Adults. Diabetes Care, 16, 157-177.
[11] King, H., Aubert, R.E. and Herman, W.H. (1996) Global Burden of Diabetes, 1995-2025 Prevalence, Numerical Estimates, and Projections. Diabetes Care, 21, 1414-1431.
[12] Sicree, R., Shaw, J. and Zimmet, P. (2009) The Global Burden, Diabetes and Impaired Glucose Tolerance. IDF Diabetes Atlas Fourth Edition, Baker IDI Heart and Diabetes Institute.
[13] McCarty, D. and Zimmet, P. (1994) Diabetes 1994 to 2010: Global Estimates and Projections. International Diabetes Institute, Melbourne.
[14] King, H., Aubert, R. and Herman, W. (1998) Global Burden of Diabetes, 1995-2025: Prevalence, Numerical Estimates and Projections. Diabetes Care, 21, 1414-1431.
[15] American Diabetes Association (2008) Economic Costs of Diabetes in the US in 2007. Diabetes Care, 31,576-615.
[16] Dall, T.M., Mann, S.E., Zhang, Y., Quick, W.W., Seifert, R.F., Martin, J., et al. (2009) Distinguishing the Economic Costs Associated with Type 1 and Type 2 Diabetes. Population Health Management, 12, 103-110.
[17] Zhang, Y., Dall, T.M., Mann, S.E., Chen, Y., Martin, J., Moore, V., et al. (2009) The Economic Costs of Undiagnosed Diabetes. Population Health Management, 12, 95-101.
[18] Zhang, Y., Dall, T.M., Chen, Y., Baldwin, A., Yang, W., Mann, S., et al. (2009) Medical Cost Associated with Prediabetes. Popul Health Manag, 12, 157-163.
[19] Chen, Y., Quick, W.W., Yang, W., Zhang, Y., Baldwin, A., Moran, J., et al. (2009) Cost of Gestational Diabetes Mellitus in the United States in 2007. Population Health Management, 12, 165-174.
[20] Shaw, J.E., Sicree, R.A. and Zimmet, P.Z. (2009) Global Estimates of the Prevalence of Diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87, 4-14.
[21] World Health Organization. Global Burden of Disease (2004) Update. Geneva: World Health Organization.
[22] Khattar, R.S., Swales, J.D., Senior, R. and Lahiri, A. (2000) Racial Variation in Cardiovascular Morbidity and Mortality in Essential Hypertension. Heart, 83, 267-271.
[23] Chaturvedi, N., Jarrett, J., Morrish, N., Keen, H. and Fuller, J.H. (1996) Differences in Mortality and Morbidity in African Caribbean and European People with Non-Insulin-Dependent Diabetes Mellitus: Result of 20-Year Follow-Up of a London Cohort of a Multinational Study. BMJ, 313, 848-852.
[24] U.K. Prospective Diabetes Study Group (1998) The Incidence of Myocardial Infarction in White, South Asian, and Afro-Caribbean Patients with Type 2 Diabetes (U.K. Prospective Diabetes Study 32). Diabetes Care, 21, 1271-1277.
[25] Balarajan, R. (1996) Ethnicity and Variations in Mortality from Coronary Heart Disease. Health Trends, 28, 45-51.
[26] Joffe, B. and Zimmet, P. (1998) The Thrifty Genotype in Type 2 Diabetes: An Unfinished Symphony Moving to Its Finale? Endocrine, 9, 139-141.
[27] Bhopal, R., Unwin, N., White, M., et al. (1999) Heterogeneity of Coronary Heart Disease Risk Factors in Indian, Pakistani, Bangladeshi, and European Origin Populations: Cross-Sectional Study. BMJ, 319, 215-220.
[28] Sundquist, J. and Winkleby, M. (2000) Country of Birth, Acculturation Status and Abdominal Obesity in a National Sample of Mexican-American Women and Men. International Journal of Epidemiology, 29, 470-477.
[29] Zimmet, P. (1982) Type 2 (Non-Insulin-Dependent) Diabetes—An Epidemiological Overview. Diabetologica, 22, 399-411.
[30] Cappucio, F.P., Cook, D.G., Atkinson, R.W. and Strazullo, P. (1997) Prevalence, Detection, and Management of Cardiovascular Risk Factors in Different Ethnic Groups in South London. Heart, 78, 555-563.
[31] Abate, N. and Chandalia, M. (2003) The Impact of Ethnicity on Type 2 Diabetes. Journal of Diabetes and Its Complications, 17, 39-58.
[32] Abolhasani, F., Tehrani, M.R.M., Tabatabaei, O. and Larijani, B. (2005) Burden of Diabetes and Its Complications in Iran in Year 2000. JDMD, 5, 130.
[33] Narayan, K.M.V., Gregg, E.W., Fagot-Campagna, A., Engelgau, M.M. and Vinicor, F. (2000) Diabetes—A Common, Growing, Serious, Costly, and Potentially Preventable Public Health Problem. Diabetes Research and Clinical Practice, 50, Suppl. 2, 77-84.
[34] Boyle, J.P., Thompson, T.J., Gregg, E.W., Barker, L.E. and Williamson, D.F. (2010) Projection of the Year 2050 Burden of Diabetes in the US Adult Population: Dynamic Modeling of Incidence, Mortality, and Prediabetes Prevalence. Population Health Metrics, 8, 29.
[35] American Diabetes Association (2008) Economic Costs of Diabetes in the U.S. in 2007. Diabetes Care, 32, 596-615.
[36] The Diabetes Prevention Program Research Group (1999) The Diabetes Prevention Program: Design and Methods for a Clinical Trial in the Prevention of Type 2 Diabetes. Diabetes Care, 22, 623-634.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.